Log in | Register

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 18, Issue 3

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Investigational Drugs, Volume 18, Issue 3 (2009)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 18, Issue 3 (2009)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Volume 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Reviews

Article

Phosphodiesterase type 5 inhibitors: a viable treatment option for lower urinary tract symptoms?

Konstantinos Hatzimouratidis

Pages: 245-254

Published online: 09 May 2009

AbstractforPhosphodiesterase type 5 inhibitors: a viable treatment option for lower urinary tract symptoms? | Full Text | References | PDF (273 KB)

54 Views
1 CrossRef citations
0Altmetric

Article

Opioid formulations in development designed to curtail abuse: who is the target?

Lynn R Webster MD FACPM FASAM, Brad Bath PhD & Robert A Medve MD

Pages: 255-263

Published online: 09 May 2009

AbstractforOpioid formulations in development designed to curtail abuse: who is the target? | Full Text | References | PDF (270.6 KB)

304 Views
46 CrossRef citations
0Altmetric

Article

Caprospinol: moving from a neuroactive steroid to a neurotropic drug

Laurent Lecanu, Laurent Tillement, Georges Rammouz, Jean Paul Tillement, Janet Greeson & Vassilios Papadopoulos

Pages: 265-276

Published online: 09 May 2009

AbstractforCaprospinol: moving from a neuroactive steroid to a neurotropic drug | Full Text | References | PDF (747.6 KB)

194 Views
12 CrossRef citations
0Altmetric

Article

Targeting multiple kinases in glioblastoma multiforme

Sith Sathornsumetee MD & David A Reardon MD

Pages: 277-292

Published online: 09 May 2009

AbstractforTargeting multiple kinases in glioblastoma multiforme | Full Text | References | PDF (274.8 KB)

245 Views
34 CrossRef citations
0Altmetric

Article

Second-generation epidermal growth factor tyrosine kinase inhibitors in non-small cell lung cancer

Deborah Mukherji MRCP MBBS & James Spicer

Pages: 293-301

Published online: 09 May 2009

AbstractforSecond-generation epidermal growth factor tyrosine kinase inhibitors in non-small cell lung cancer | Full Text | References | PDF (220 KB)

156 Views
14 CrossRef citations
0Altmetric

Drug Evaluations

Article

Tesamorelin, a human growth hormone releasing factor analogue

Ying Wang PhD & Brian Tomlinson MD FRCP

Pages: 303-310

Published online: 22 Jan 2009

AbstractforTesamorelin, a human growth hormone releasing factor analogue | Full Text | References | PDF (225.2 KB)

189 Views
11 CrossRef citations
0Altmetric

Article

Targeting apoptosis: preclinical and early clinical experience with mapatumumab, an agonist monoclonal antibody targeting TRAIL-R1

Patricia Moretto & Sébastien J Hotte MD MSc (HRM) FRCPC

Pages: 311-325

Published online: 09 May 2009

AbstractforTargeting apoptosis: preclinical and early clinical experience with mapatumumab, an agonist monoclonal antibody targeting TRAIL-R1 | Full Text | References | PDF (936.6 KB)

161 Views
17 CrossRef citations
0Altmetric

Article

Dapagliflozin: an emerging treatment option in type 2 diabetes

Mark Kipnes

Pages: 327-334

Published online: 09 May 2009

AbstractforDapagliflozin: an emerging treatment option in type 2 diabetes | Full Text | References | PDF (388.4 KB)

434 Views
13 CrossRef citations
0Altmetric

Article

S-1: a promising new oral fluoropyrimidine derivative

Muhammad Wasif Saif, Kostas N Syrigos & Nikos A Katirtzoglou

Pages: 335-348

Published online: 09 May 2009

AbstractforS-1: a promising new oral fluoropyrimidine derivative | Full Text | References | PDF (412.8 KB)

331 Views
66 CrossRef citations
0Altmetric

Article

Review of rifaximin as treatment for SIBO and IBS

Mark Pimentel MD FRCP(C)

Pages: 349-358

Published online: 09 May 2009

AbstractforReview of rifaximin as treatment for SIBO and IBS | Full Text | References | PDF (498.7 KB)

2062 Views
72 CrossRef citations
0Altmetric

Article

Exenatide once weekly for the treatment of type 2 diabetes

James Malone MD, Michael Trautmann MD, Ken Wilhelm MD, Kristin Taylor PhD & David M Kendall MD

Pages: 359-367

Published online: 09 May 2009

AbstractforExenatide once weekly for the treatment of type 2 diabetes | Full Text | References | PDF (288.2 KB)

433 Views
37 CrossRef citations
0Altmetric

Key Paper Evaluation

Article

Daclizumab a novel corticosteroid-sparing therapy for asthma?

Evaluation of: Busse WW, Israel E, Nelson HS, et al. Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial. Am J Respir Crit Care Med 2008;178:1002-8

Sabina A Antoniu MD PhD

Pages: 369-371

Published online: 09 May 2009

AbstractforDaclizumab a novel corticosteroid-sparing therapy for asthma? | Full Text | References | PDF (197.1 KB)

67 Views
6 CrossRef citations
0Altmetric

Meeting Highlights

Article

Highlights of regional meeting of Italian Southern Oncological Group (GOIM): focus on hepatocellular carcinoma: biological and clinical background, therapeutic guide-lines and perspectives

7 November 2008, Naples, Italy

Raffaele Addeo, Michele Caraglia & Salvatore Del Prete

Pages: 373-378

Published online: 09 May 2009

AbstractforHighlights of regional meeting of Italian Southern Oncological Group (GOIM): focus on hepatocellular carcinoma: biological and clinical background, therapeutic guide-lines and perspectives | Full Text | References | PDF (230.8 KB)

87 Views
11 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Prospects of focal adhesion kinase inhibitors as a cancer therapy in preclinical and early phase study

Jiaming Gao et al.

Review Article | Published online: 27 Apr 2024

Investigational farnesoid X receptor agonists for the treatment of primary biliary cholangitis

Prithvi Reddy Akepati et al.

Review Article | Published online: 27 Apr 2024

Targeting diarrhea-predominant irritable bowel syndrome: hopes or hypes?

Gabrio Bassotti

Editorial | Published online: 25 Apr 2024

Free Access

Safety, tolerability, and pharmacokinetics of the novel RdRp inhibitor SHEN26 against SARS-CoV-2: a randomized, placebo-controlled, double-blind phase I study in healthy subjects

Cheng Sun et al.

Article | Published online: 25 Apr 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.18, Iss.3, 2009)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?